Cargando…

Comparison of FIB-4 index and aspartate aminotransferase to platelet ratio index on carcinogenesis in chronic hepatitis B treated with entecavir

Aims: We sought to compare the effects of FIB-4 index and aspartate aminotransferase to platelet ratio index (APRI) on hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients undergoing entecavir (ETV) therapy. Patient and methods: A total of 338 nucleosides analogue therapy n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishikawa, Hiroki, Nishijima, Norihiro, Enomoto, Hirayuki, Sakamoto, Azusa, Nasu, Akihiro, Komekado, Hideyuki, Nishimura, Takashi, Kita, Ryuichi, Kimura, Toru, Iijima, Hiroko, Nishiguchi, Shuhei, Osaki, Yukio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327364/ https://www.ncbi.nlm.nih.gov/pubmed/28243319 http://dx.doi.org/10.7150/jca.16523

Ejemplares similares

A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation
por: Nishikawa, Hiroki, et al.
Publicado: (2016)

Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis
por: Nishikawa, Hiroki, et al.
Publicado: (2017)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Clinical Implication of Performance Status in Patients with Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Transcatheter Arterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Clinical Outcome and Safety in Elderly Patients
por: Nishikawa, Hiroki, et al.
Publicado: (2014)

Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion
por: Takeda, Haruhiko, et al.
Publicado: (2019)

Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase
por: Tan, You-Wen, et al.
Publicado: (2017)

Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores
por: Okan, Huseyin Dogus, et al.
Publicado: (2023)

Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies
por: Enomoto, Hirayuki, et al.
Publicado: (2020)

Dynapenia Rather Than Sarcopenia Is Associated with Metabolic Syndrome in Patients with Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Combined grip strength and calf circumference as a useful prognostic system in patients with liver diseases: a large cohort study
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver
por: Kusumawati, Ninung RD, et al.
Publicado: (2013)

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy
por: NISHIKAWA, HIROKI, et al.
Publicado: (2013)

Relationship Between Hepatic Steatosis and the Elevation of Aminotransferases in HBV-Infected Patients With HBe-Antigen Negativity and a Low Viral Load
por: Enomoto, Hirayuki, et al.
Publicado: (2016)

Frailty and Sleep Disorder in Chronic Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

What is the performance of the Aspartate Aminotransferase to platelets Ratio Index in patients With Chronic Liver Disease?
por: Zarski, Jean Pierre
Publicado: (2011)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus
por: Nishijima, Norihiro, et al.
Publicado: (2018)

Underwater endoscopic mucosal resection: a new endoscopic method for resection of rectal neuroendocrine tumor grade 1 (carcinoid) ≤ 10 mm in diameter
por: Yamashina, Takeshi, et al.
Publicado: (2018)

Aspartate aminotransferase to platelet ratio index for the assessment of liver fibrosis severity in patients with chronic hepatitis
por: Sirli, Roxana, et al.
Publicado: (2011)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy
por: Yuri, Yukihisa, et al.
Publicado: (2017)

Cold snare polypectomy reduced delayed postpolypectomy bleeding compared with conventional hot polypectomy: a propensity score-matching analysis
por: Yamashina, Takeshi, et al.
Publicado: (2017)

Anthropometric Measurements and Frailty in Patients with Liver Diseases
por: Nishikawa, Hiroki, et al.
Publicado: (2020)

Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
por: Ishii, Noriko, et al.
Publicado: (2020)

Grip Strength: A Useful Marker for Composite Hepatic Events in Patients with Chronic Liver Diseases
por: Yoh, Kazunori, et al.
Publicado: (2020)

Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma
por: Cheng, JiWen, et al.
Publicado: (2016)

Can first-trimester aspartate aminotransferase/platelet ratio index score predict intrahepatic cholestasis of pregnancy?
por: Gok, Koray, et al.
Publicado: (2023)

Increased preoperative aspartate aminotransferase-to-platelet ratio index predicts complications following total shoulder arthroplasty
por: Liu, Steven H., et al.
Publicado: (2023)

The role of preoperative aspartate aminotransferase-to-platelet ratio index in predicting complications following total hip arthroplasty
por: McLellan, M. A., et al.
Publicado: (2023)

Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
por: Dong, Bingtian, et al.
Publicado: (2022)

Aspartate aminotransferase/alanine aminotransferase ratio and subsequent cancer development
por: Kobayashi, Daiki, et al.
Publicado: (2021)

Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI)
por: Wan, Minjie, et al.
Publicado: (2021)

Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report
por: Zhan, Meng-Ru, et al.
Publicado: (2019)

Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
por: Kawamoto, Ryuichi, et al.
Publicado: (2012)

The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice
por: Kim, Earl, et al.
Publicado: (2013)

Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma
por: He, Chao, et al.
Publicado: (2017)

Usefulness of aspartate aminotransferase to platelet ratio index as a prognostic factor following hepatic resection for hepatocellular carcinoma
por: Matsumoto, Michinori, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fs273qcr105crqb5euq0nu9du9